Biliary physiology and disease: reflections of a physician-scientist
- PMID: 20373364
- DOI: 10.1002/hep.23472
Biliary physiology and disease: reflections of a physician-scientist
Abstract
A review is presented of Gustav Paumgartner's five decades of research and practice in hepatology focusing on biliary physiology and disease. It begins with studies of the excretory function of the liver including hepatic uptake of indocyanine green, bilirubin, and bile acids. The implications of these studies for diagnosis and understanding of liver diseases are pointed out. From there, the path of scientific research leads to investigations of hepatobiliary bile acid transport and the major mechanisms of bile formation. The therapeutic effects of the hydrophilic bile acid, ursodeoxycholic acid, have greatly stimulated these studies. Although ursodeoxycholic acid therapy for dissolution of cholesterol gallstones and some other nonsurgical treatments of gallstones were largely superseded by surgical techniques, ursodeoxycholic acid is currently considered the mainstay of therapy of some chronic cholestatic liver diseases, such as primary biliary cirrhosis. The major mechanisms of action of ursodeoxycholic acid therapy in cholestatic liver diseases are discussed. An attempt is made to illustrate how scientific research can lead to advances in medical practice that help patients.
Similar articles
-
Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.J Hepatol. 1995 Sep;23(3):283-9. J Hepatol. 1995. PMID: 8550992
-
Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.Ital J Gastroenterol. 1992 Jan;24(1):31-5. Ital J Gastroenterol. 1992. PMID: 1571577 Review.
-
Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.Hepatology. 1991 Jun;13(6):1076-83. Hepatology. 1991. PMID: 2050325
-
Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease.Neth J Med. 1993 Dec;43(5-6):233-8. Neth J Med. 1993. PMID: 8107930 Review.
-
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.Gastroenterologist. 1994 Mar;2(1):74-9. Gastroenterologist. 1994. PMID: 8055235 Review.
Cited by
-
Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):657-667. doi: 10.1007/s13318-016-0382-x. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27778300
-
A review of indocyanine green fluorescent imaging in surgery.Int J Biomed Imaging. 2012;2012:940585. doi: 10.1155/2012/940585. Epub 2012 Apr 22. Int J Biomed Imaging. 2012. PMID: 22577366 Free PMC article.
-
Scoparone potentiates transactivation of the bile salt export pump gene and this effect is enhanced by cytochrome P450 metabolism but abolished by a PKC inhibitor.Br J Pharmacol. 2011 Nov;164(5):1547-57. doi: 10.1111/j.1476-5381.2011.01522.x. Br J Pharmacol. 2011. PMID: 21649640 Free PMC article.
-
Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state.Nat Rev Microbiol. 2011 Jan;9(1):9-14. doi: 10.1038/nrmicro2490. Epub 2010 Nov 29. Nat Rev Microbiol. 2011. PMID: 21113180 Free PMC article. Review.
-
The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration.Pak J Med Sci. 2013 Jan;29(1):187-90. doi: 10.12669/pjms.291.2798. Pak J Med Sci. 2013. PMID: 24353537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources